The new, one-day conference will take place in Bethesda, MD on May 5.
Photo © iStockphoto.com/DSGpro
The Council for Responsible Nutrition (CRN; Washington, DC) will be hosting a new, one-day conference this May.
Titled “The Regulatory Summit,” the new event will feature interactive sessions to “help attendees formulate clear direction and options for addressing current regulatory compliance matters confronting dietary supplements and functional foods,” according to the announcement from CRN. It will take place on May 5 at the Hyatt Regency in Bethesda, MD.
Session leaders will include regulatory experts from consulting firms, companies, law firms, and quality control laboratories. FDA regulatory officials from different units of the agency will also be in attendance as both presenters and observers, which CRN says will allow for a dialogue between the supplements industry and the government authority charged with regulating it.
“We anticipate this conference will have broad appeal for regulatory professionals in the dietary supplement and functional food industry, including senior executives, regulatory/quality managers, and technical scientists,” said Duffy MacKay, ND, CRN’s senior vice president of scientific and regulatory affairs. “We’ll cover topics of interest in regulatory affairs, as well as quality control/quality assurance.”
MacKay also encourages companies to send more than one person because the conference will include team-building opportunities around creating strategies to prevent, address, and correct potential regulatory problems.
Soon after the Regulatory Summit, CRN is co-hosting the fourth-annual Legal, Regulatory and Compliance Forum on June 27–29, in conjunction with the American Conference Institute (ACI). The Forum will take place in New York City and will focus on current legal and compliance issues impacting the industry.
More details and registration information for The Regulatory Summit can be found here.
Read more:
CRN Requires Members Submit Product Labels to ODS Database
First Broccoli-Source Glucoraphanin Granted GRAS Status
What Has FDA Done to Stop Industry Lawbreakers in the Last Year?
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.